518 related articles for article (PubMed ID: 21309672)
21. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory bowel disease cancer surveillance in a tertiary referral hospital: attitudes and practice.
Verschuren EC; Ong DE; Kamm MA; Desmond PV; Lust M
Intern Med J; 2014 Jan; 44(1):40-9. PubMed ID: 24015799
[TBL] [Abstract][Full Text] [Related]
23. Reduction of colorectal cancer risk in patients with Crohn's disease.
Lichtenstein GR
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S16-24. PubMed ID: 12478240
[TBL] [Abstract][Full Text] [Related]
24. Colon cancer surveillance in inflammatory bowel disease patients: current and emerging practices.
Velayos F
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):817-25. PubMed ID: 19090741
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
26. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
27. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
28. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
30. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort.
Vienne A; Simon T; Cosnes J; Baudry C; Bouhnik Y; Soulé JC; Chaussade S; Marteau P; Jian R; Delchier JC; Coffin B; Admane H; Carrat F; Drouet E; Beaugerie L
Aliment Pharmacol Ther; 2011 Jul; 34(2):188-95. PubMed ID: 21615760
[TBL] [Abstract][Full Text] [Related]
31. [Surveillance of patients with inflammatory bowel diseases].
Moshkowitz M; Kariv R; Half B; Vilkin A; Levi Z; Niv Y; Dotan I;
Harefuah; 2011 Apr; 150(4):389-91, 417. PubMed ID: 22164923
[TBL] [Abstract][Full Text] [Related]
32. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
33. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
Ahmadi A; Polyak S; Draganov PV
World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when?
Baumgart DC
Dig Dis; 2011; 29 Suppl 1():32-5. PubMed ID: 22104750
[TBL] [Abstract][Full Text] [Related]
37. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
38. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
39. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
40. Distress among inflammatory bowel disease patients at high risk for colorectal cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support.
Rini C; Jandorf L; Valdimarsdottir H; Brown K; Itzkowitz SH
Psychooncology; 2008 Apr; 17(4):354-62. PubMed ID: 17607717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]